Abstract Title: currently loading...

information currently loading...

Loading ... please wait
timer Loading ... please wait

Free Paper Session 2: Vascular Diseases & Diabetic Retinopathy I

09:00 - 10:30 | 20 September | Room: Room D1.

Back to Previous

09:06Quantitative assessment of outer retinal layer and photoreceptor outer segment layer and their relation to visual acuity in diabetic macular edema
A. Abdelhamid Kuwait
09:12A phase IV study to assess efficacy and safety of a treatandextend regimen of aflibercept for treatment of macular edema secondary to central retinal vein occlusion in naïve patients. Neuton study
J. Garcia-Arumi Spain
09:18Management of Coats’ disease microaneurysms with FFAguided navigated laser
I. Kozak United Arab Emirates
09:24Multimodal imaging and functional correlation with microperimetry in patients with macular telangiectasia type 2
I. Carneiro Portugal
09:30Relationship of dietary fish intake to diabetic retinopathy in patients with type 2 diabetes
L. Schmetterer Singapore
09:36Randomized, prospective, doublemasked, controlled phase 2b trial to evaluate the safety & efficacy of ALG1001 (Luminate®) in diabetic macular edema (DME)
P. Dugel United States
09:42Influence of the vitreomacular interface on the course of diabetic macular edema (DME) after treatment with intravitreal injections of antivascular endothelial growth factor agents (antiVEGF)
S. Gómez Sánchez Spain
09:48Choroidal structure changes in diabetic patients without diabetic retinopathy
R. Figueiredo Portugal
09:54The first report comparing the 3 year outcomes of ILUVIEN (fluocinolone acetonide) in vitrectomised and nonvitrectomised eyes in patients with DME – results from RETROIDEAL
A. Augustin Germany
10:00Effect of intravitreal conbercept on aqueous humor cytokines in macular edema secondary to central retinal vein occlusion
H. Zhang China
10:06Cardiovascular risk factors impact in perifoveal flow in type 1 diabetes mellitus assessed by OCT angiography
A. Alé-Chilet Spain
10:12Efficacy and safety of intravitreal aflibercept injection in Japanese patients with neovascular glaucoma: Outcomes from the phase 3 VEGA study
M. Inatani Japan
10:18Ranibizumab versus aflibercept for myopic choroidal neovascularization: 24 month results in reallife data
A. Korol Ukraine
Back to Previous

Sign up to EURETINA

© EURETINA All rights reserved
Loading please wait